Literature DB >> 1608349

Lymphoma in Sjogren's syndrome.

N A Pavlidis1, A A Drosos, C Papadimitriou, N Talal, H M Moutsopoulos.   

Abstract

Sjogren's syndrome is an autoimmune disease with a known predisposition for lymphoma development. Eight of 120 patients with primary Sjogren's syndrome followed at the University of Ioannina over the past 7 years developed non-Hodgkin's lymphoma diagnosed according to the Kiel classification. The lymphomas differed by location and grading. Six were called low grade (immunocytoma) and two intermediate grade non-Hodgkin's lymphomas. Five of the immunocytomas involved the minor salivary or lacrimal glands. Immunoperoxidase staining for light chains revealed monoclonal populations. Two patients showed spontaneous regression not previously reported in Sjogren's syndrome. Thus, in Sjogren's syndrome, low grade non-Hodgkin's lymphomas and especially immunocytomas are the most common lymphomas. These lymphomas tend to evolve very slowly and may regress spontaneously. Given these facts, a conservative approach to treatment is indicated in those patients with only localized disease.

Entities:  

Mesh:

Year:  1992        PMID: 1608349     DOI: 10.1002/mpo.2950200403

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

Review 1.  Therapy of Sjögren's syndrome.

Authors:  N M Moutsopoulos; H M Moutsopoulos
Journal:  Springer Semin Immunopathol       Date:  2001

2.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 3.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Hashimoto's thyroiditis, Sjogren's syndrome and orbital lymphoma.

Authors:  G T Ko; C C Chow; V T Yeung; H Chan; C S Cockram
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

5.  Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.

Authors:  J E Tomkiel; H Alansari; N Tang; J B Virgin; X Yang; P VandeVord; R L Karvonen; J L Granda; M J Kraut; J F Ensley; F Fernández-Madrid
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

6.  A case of reactive plasmacytosis mimicking multiple myeloma in a patient with primary Sjogren's syndrome.

Authors:  Jisoo Lee; Ji-Eun Chang; Young-Joo Cho; Woon Seop Han
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

7.  Predictable biomarkers of developing lymphoma in patients with Sjögren syndrome: a nationwide population-based cohort study.

Authors:  Yu-Hsiang Chiu; Chi-Hsiang Chung; Kuen-Tze Lin; Chin-Sheng Lin; Jia-Hong Chen; Hsiang-Cheng Chen; Ren-Yeong Huang; Chi-Tsung Wu; Feng-Cheng Liu; Wu-Chien Chien
Journal:  Oncotarget       Date:  2017-07-25

8.  Minor Salivary Gland Biopsy in Diagnosis of Sjögren's Syndrome.

Authors:  Alex J Gordon; Aneek Patel; Fang Zhou; Cheng Liu; Amit Saxena; Paula Rackoff; Babak Givi
Journal:  OTO Open       Date:  2022-07-25

Review 9.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.